• Company
• Companies produced KRW 66.7B finished drugs a year
• by Chon, Seung-Hyun Jan 24, 2025 05:52am

• Company
• Will long-acting HIV treatment be included in the reimb list
• by Eo, Yun-Ho Jan 24, 2025 05:52am

• Company
• The era of compound management for obesity
• by Whang, byung-woo Jan 23, 2025 05:54am

• Company
• MET inhibitor Tepmetko enters last stage to reimb in KOR
• by Eo, Yun-Ho Jan 23, 2025 05:54am

• Company
• "C-Trelin proven effective for SCD treatment…reimb needed"
• by Lee, Seok-Jun Jan 22, 2025 05:55am

• Company
• "Foreign drug price re-evaluation, unfair direct comparison"
• by Kim, Jin-Gu Jan 22, 2025 05:54am

• Company
• Leqembi may be prescribed in general hospitals in Korea
• by Eo, Yun-Ho Jan 22, 2025 05:54am

• Company
• HK Inno.N and Roche will co-promote Avastin
• by Chon, Seung-Hyun Jan 22, 2025 05:54am

• Company
• Astellas 'Xtandi' offers high efficacy with low side effects
• by Whang, byung-woo Jan 21, 2025 05:54am

• Company
• Darzalex is granted reimb extension in Korea
• by Moon, sung-ho Jan 21, 2025 05:54am